These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30210925)

  • 1. Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study.
    Dai D; Jin H; Wang X
    Am J Cancer Res; 2018; 8(8):1576-1585. PubMed ID: 30210925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
    Jing N; Ma MW; Gao XS; Liu JT; Gu XB; Zhang M; Zhao B; Wang Y; Wang XL; Jia HX
    Ann Transl Med; 2020 Nov; 8(21):1447. PubMed ID: 33313192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study.
    Liu X; Yue S; Huang H; Duan M; Zhao B; Liu J; Xiang T
    Front Med (Lausanne); 2021; 8():705515. PubMed ID: 34621757
    [No Abstract]   [Full Text] [Related]  

  • 5. A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery.
    Chai X; Sun MY; Jia HY; Wang M; Cao L; Li ZW; Wang DW
    PeerJ; 2019; 7():e7837. PubMed ID: 31632852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
    Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
    Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer.
    Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
    Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
    Cui J; Jiang H
    Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort.
    Qiu Y; Chen Y; Shen H; Yan S; Li J; Wu W
    Front Oncol; 2024; 14():1388869. PubMed ID: 38919536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
    Pan WK; Ren SY; Zhu LX; Lin BC
    Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
    Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
    BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database.
    Zhou HL; Chen DD
    Clin Breast Cancer; 2023 Apr; 23(3):e85-e94. PubMed ID: 36669957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
    Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
    Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.
    Cui X; Song D; Li X
    Front Oncol; 2020; 10():636549. PubMed ID: 33628740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
    Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
    World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram prediction for the survival of patients with triple negative breast cancer.
    Lin Y; Fu F; Lin S; Qiu W; Zhou W; Lv J; Wang C
    Oncotarget; 2018 Aug; 9(63):32108-32118. PubMed ID: 30181802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery.
    Lin WX; Xie YN; Chen YK; Cai JH; Zou J; Zheng JH; Liu YY; Li ZY; Chen YX
    World J Clin Cases; 2022 Nov; 10(31):11338-11348. PubMed ID: 36387832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of nomograms integrating immune-related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple-negative breast cancer: A gene expression-based retrospective study.
    Wang K; Li HL; Xiong YF; Shi Y; Li ZY; Li J; Zhang X; Li HY
    Cancer Med; 2019 Feb; 8(2):686-700. PubMed ID: 30677255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.
    Shen K; Yao L; Wei J; Luo Z; Yu W; Zhai H; Wang J; Chen L; Fu D
    Cancer Med; 2019 Dec; 8(18):7890-7902. PubMed ID: 31663683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer.
    Guo LW; Jiang LM; Gong Y; Zhang HH; Li XG; He M; Sun WL; Ling H; Hu X
    Cancer Manag Res; 2018; 10():5881-5894. PubMed ID: 30510456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.